


ABAC Therapeutics
Biotechnology Research • Esplugues de Llobregat, Catalonia, Spain • 1-10 Employees
Company overview
| Headquarters | C Joan XXIII 10,, Esplugues de Llobregat, Barcelona 08950, ES |
| Phone number | +34932301154 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Drug Discovery, Antibacterials |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
Key Contact at ABAC Therapeutics
Antoni Torrens Jover
Senior Vice President Medicinal Chemistry
About ABAC Therapeutics
ABAC Therapeutics is committed to finding therapeutic solutions for patients that are infected with highly antibiotic-resistant bacterial pathogens and that leave affected patients with few (or no) treatment options. Heads of national healthcare services, professional infectious diseases organizations and infectious diseases experts are warning that we are facing a return to a pre-antibiotic era. Infections with such “superbugs” are increasing in both severity and frequency, and new drugs are needed to treat them now. ABAC Therapeutics is focused on delivering new pathogen-specific antibacterials for the treatment of multi-drug resistant bugs.
ABAC Therapeutics revenue & valuation
| Annual revenue | $5,020,000 |
| Revenue per employee | $1,674,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $16,100,000 |
| Total funding | $20,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
ABAC Therapeutics Tech Stack
Discover the technologies and tools that power ABAC Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Video players
JavaScript libraries
JavaScript libraries
Cookie compliance
Maps
WordPress themes
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
Frequently asked questions
4.8
40,000 users



